feedback

Activity Chair

Stephen B. Hanauer, MD
Clifford Joseph Barborka Professor of Medicine
Northwestern University Feinberg School of Medicine
Medical Director, Digestive Health Center
Chicago, IL
Disclosure:
Consulting Fee: Merck


Faculty

David G. Binion, MD, AGAF, FACG
Co-Director, IBD Center
Director, Translational IBD Research
Director, Nutrition Support Service
Professor of Medicine, Clinical and Translational Science
University of Pittsburgh School of Medicine
Pittsburgh, PA
Disclosure:
Consulting Fee: AbbVie, Janssen, Synthetic Biologics, UCB
Contracted Research: Janssen, Merck, UCB


Carl V. Crawford, Jr., MD
Assistant Professor of Clinical Medicine
Program Director, Gastroenterology and Hepatology Fellowship
New York Presbyterian Hospital - Weill Cornell Medicine
New York, NY
Disclosure:
Speakers Bureau: EnteraHealth, Merck, Valeant
Fees for Non-CME Services received Directly from a Commercial Interest or its Agent: EnteraHealth, Merck, Valeant
Contracted Research: Rebiotix, Seres


Erik R. Dubberke, MD, MSPH
Associate Professor of Medicine
Director, Section of Transplant Infectious Diseases
Washington University School of Medicine
St. Louis, MO
Disclosure:
Consulting Fee: Merck, Rebiotix, Sanofi Pasteur, Summit
Contracted Research: Merck, Rebiotix, Sanofi Pasteur


Reviewer

Craig Aronchick, MD
Disclosure: No relevant financial relationships to disclose.

Vindico Medical Education Staff: No relevant financial relationships to disclose.

Signed Disclosure(s) are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Accredited By

This continuing medical education activity is provided by

Activity Details

Credit Type: AMA PRA Category 1 Credit
Credit Amount: 1.5
Release Date: December 12, 2016
Expiration Date: December 12, 2017
Estimated Time to Complete Activity: 1.5 hours
Registration Required: No
Fee for Activity: No

Activity Description

Clostridium difficile (C. difficile) is an important cause of infectious disease death in the United States, constituting a serious public health burden. According to the Centers for Disease Control and Prevention, nearly 250,000 people become infected with C. difficile while in hospitals each year, surpassing the number of methicillin-resistant Staphylococcus aureus infections. However, C. difficile infection (CDI) is not an exclusively nosocomial problem, and approximately one-third of infections are community associated. In this activity, leading clinicians will discuss the incidence and burden of CDI; identify patients at risk for CDI based on history, presentation, and risk stratification; and analyze current treatment strategies for CDI, as well as therapeutic agents and regimens that reduce the occurrence of antimicrobial resistance and improve outcomes for patients with CDI.

Agenda

Clostridium difficile Infection: A Community Affair
Carl V. Crawford, Jr., MD

Treating a Difficile Problem – Current Status
Erik R. Dubberke, MD, MSPH

Case Presentation – Treatment of Recurrent CDI
Erik R. Dubberke, MD, MSPH

Clostridium difficile Infection (CDI) Research – An Evolving Science
David G. Binion, MD, AGAF, FACG

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Describe the incidence and burden of CDI and its increasing incidence outside the hospital setting.
  • Identify patients at risk for CDI based on history, presentation, and the appropriate risk stratification techniques.
  • Analyze current treatment strategies for CDI, antimicrobial resistance patterns, and the potential for the disease to recur.
  • Examine therapeutic agents and regimens that reduce the occurrence of antimicrobial resistance and improve outcomes for patients with CDI.

Target Audience

The intended audience for this activity is gastroenterologists and other health care professionals involved in the treatment of patients with Clostridium difficile.

Conflict of Interest Policy / Disclosure Statement

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage.

Accreditation Statement

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Commercial Support

This activity is supported by an educational grant from Merck & Co., Inc.

How to Participate in this Activity and Obtain CME Credit:

To participate in this CME activity, you must read the objectives, answer the pretest questions, view content, complete the CME posttest, and complete and submit the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclaimer Statement / Disclosure of Unlabeled Use

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

Contact Information for Questions About the Activity

Vindico Medical Education: cme@VindicoCME.com or 856-994-9400, ext. 504

Hardware / Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.